- Organizations: Microsurgical Technologies (MST)
Research
Safety and efficacy data supports Vista 1-Step vitrectomy probe
A total of 86% of pseudophakic patients reported a complete resolution of symptoms by postop month 3 following limited vitreous removal procedure.Business